Previous Article | Next Article ![]()
J. Bacteriol., 08 1995, 4669-4675, Vol 177, No. 16
C Fermer, BE Kristiansen, O Skold and G Swedberg
Sulfonamide resistance in Neisseria meningitidis is mediated by altered
forms of the chromosomal gene for the drug target enzyme dihydropteroate
synthase. Sulfonamides have been used for decades both for prophylaxis and
the treatment of meningococcal disease, and resistance is common. Two types
of resistance determinants have been identified, and regions important for
drug insusceptibility to the corresponding enzyme have been defined by
site-directed mutagenesis. Both types of resistance traits have spread
among strains of N. meningitidis of different serogroups and serotypes, and
the large differences at the nucleotide level in a comparison of the
resistance genes with the dhps genes of susceptible meningococci indicate
the origin of one or maybe both types in other Neisseria species. One
sulfonamide-sensitive strain of N. meningitidis was found to have a mosaic
dhps gene with a central part identical to the corresponding part of a
gonococcal strain. This observation supports the idea of an interspecies
transfer of genetic material in Neisseria species as a mechanism for the
development of chromosomally mediated resistance.
Copyright © 1995, American Society for Microbiology
Sulfonamide resistance in Neisseria meningitidis as defined by site- directed mutagenesis could have its origin in other species
Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Sweden.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |